Alvotech (NASDAQ:ALVOW – Get Free Report) traded up 46.7% on Wednesday . The stock traded as high as $0.22 and last traded at $0.22. Approximately 100 shares changed hands during mid-day trading, a decline of 98% from the average daily volume of 5,097 shares. The stock had previously closed at $0.15.
Alvotech Price Performance
The business has a 50 day moving average price of $0.21 and a 200-day moving average price of $0.29.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Read More
- Five stocks we like better than Alvotech
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
